We are live on ! Find out more
IAM

Innovis Asset Management Portfolio holdings

AUM $260M
1-Year Est. Return 28.13%
This Fund
S&P 500
This Quarter Est. Return
+10.77%
1 Year Est. Return
+28.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$271M
AUM Growth
+$24.2M
Cap. Flow
+$3.94M
Cap. Flow %
1.45%
Top 10 Hldgs %
35%
Holding
186
New
25
Increased
37
Reduced
82
Closed
24

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$4.52M
2
ROK icon
Rockwell Automation
ROK
+$4.16M
3
NEM icon
Newmont
NEM
+$3.45M
4
EMR icon
Emerson Electric
EMR
+$3.41M
5
MSFT icon
Microsoft
MSFT
+$2.94M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.32M
2
FCX icon
Freeport-McMoran
FCX
+$3.32M
3
CTVA icon
Corteva
CTVA
+$3.26M
4
DVN icon
Devon Energy
DVN
+$3.24M
5
UNH icon
UnitedHealth
UNH
+$2.68M

Sector Composition

Rank Sector Weight
1 Technology 31.6%
2 Healthcare 22.77%
3 Financials 8.72%
4 Energy 6.58%
5 Consumer Staples 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$21.9M 8.1%
113,131
-3,375
-3% -$588K
NVDA icon
2
NVIDIA
NVDA
$5.25T
$9.97M 3.68%
235,730
-3,610
-2% -$120K
ISRG icon
3
Intuitive Surgical
ISRG
$132B
$8.52M 3.15%
24,916
-422
-2% -$128K
MRK icon
4
Merck
MRK
$366B
$8.45M 3.12%
73,233
+17,377
+31% +$1.97M
NEM icon
5
Newmont
NEM
$135B
$8.02M 2.96%
188,110
+76,052
+68% +$3.45M
VRTX icon
6
Vertex Pharmaceuticals
VRTX
$137B
$7.93M 2.93%
22,539
+3,969
+21% +$1.34M
PANW icon
7
Palo Alto Networks
PANW
$303B
$7.72M 2.85%
60,418
-164
-0.3% -$17.1K
HES
8
DELISTED
Hess
HES
$7.62M 2.81%
56,040
-170
-0.3% -$23.3K
P
9
Everpure Inc
P
$31B
$7.34M 2.71%
199,371
+380
+0.2% +$10.8K
ORCL icon
10
Oracle
ORCL
$435B
$7.25M 2.68%
60,899
-19,938
-25% -$2.06M
COST icon
11
Costco
COST
$419B
$7.22M 2.67%
13,411
-237
-2% -$120K
CBOE icon
12
Cboe Global Markets
CBOE
$32.4B
$7.04M 2.6%
50,991
-192
-0.4% -$26.2K
GOOGL icon
13
Alphabet (Google) Class A
GOOGL
$4.24T
$6.29M 2.32%
52,526
-35
-0.1% -$4.03K
EMR icon
14
Emerson Electric
EMR
$86.6B
$6.02M 2.22%
66,604
+40,539
+156% +$3.41M
ENPH icon
15
Enphase Energy
ENPH
$4.92B
$5.93M 2.19%
35,398
+544
+2% +$97.2K
CVX icon
16
Chevron
CVX
$396B
$5.83M 2.15%
37,048
-306
-0.8% -$49.1K
TMO icon
17
Thermo Fisher Scientific
TMO
$230B
$5.74M 2.12%
11,008
+542
+5% +$292K
BSX icon
18
Boston Scientific
BSX
$67.9B
$5.74M 2.12%
106,045
+30,340
+40% +$1.58M
UNH icon
19
UnitedHealth
UNH
$353B
$5.57M 2.06%
11,595
-5,483
-32% -$2.68M
V icon
20
Visa
V
$712B
$5.48M 2.02%
23,071
– –
AMD icon
21
Advanced Micro Devices
AMD
$760B
$4.96M 1.83%
43,576
+14,934
+52% +$1.55M
DXCM icon
22
DexCom
DXCM
$34.3B
$4.8M 1.77%
+37,345
New +$4.52M
ROK icon
23
Rockwell Automation
ROK
$47.8B
$4.74M 1.75%
+14,393
New +$4.16M
BRK.B icon
24
Berkshire Hathaway Class B
BRK.B
$1.08T
$4.65M 1.72%
13,643
-4
-0% -$1.3K
MSFT icon
25
Microsoft
MSFT
$3.81T
$4.47M 1.65%
13,133
+9,374
+249% +$2.94M
1
2 3 4 5

Similar funds

RCGI
Ribbit Capital GP II Palo Alto, California $260M AUM 2.87% 1-Year Est. Return
RBGI
Ribbit Bullfrog GP II Palo Alto, California $258M AUM 33.43% 1-Year Est. Return
AEPLI
AH Equity Partners LSV III Menlo Park, California $262M AUM 59.24% 1-Year Est. Return
PWM
PRW Wealth Management Quincy, Massachusetts $262M AUM 22.64% 1-Year Est. Return
T
TRUADVICE Sarasota, Florida $255M AUM 14.45% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
W
WealthOne Albany, New York $248M AUM 17.79% 1-Year Est. Return

Innovis Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Innovis Asset Management held 186 positions worth $271M, up 9.8% from $247M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Innovis Asset Management's Q2 2023 filing shows 25 new, 37 increased, 82 reduced and 24 closed positions. Its largest new stake was DexCom: 37,345 shares worth $4.8M. The largest sale was Pfizer, an estimated $5.32M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Innovis Asset Management's largest Q2 2023 buy was DexCom: 37,345 shares worth $4.8M.
  • Innovis Asset Management added most to Newmont in Q2 2023, an estimated $3.45M increase.
  • Innovis Asset Management's biggest Q2 2023 reduction was Pfizer, cutting an estimated $5.32M.
  • Innovis Asset Management fully exited Freeport-McMoran in Q2 2023, selling an estimated $3.32M.
  • Innovis Asset Management's ten largest holdings make up 35% of its $271M portfolio in Q2 2023.
  • Innovis Asset Management opened 25 new positions and closed 24 in Q2 2023.
  • Innovis Asset Management's portfolio value rose 9.8% quarter-over-quarter to $271M.

Based on Innovis Asset Management's 13F filing for Q2 2023, filed 3 Aug 2023.